Jacopo Giaretta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jacopo Giaretta has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Syamak Farajikhah
School of Chemical and Biomolecular Engineering The University of Sydney Sydney NSW Australia
12 shared publications Fariba Dehghani
School of Chemical and Biomolecular Engineering, The University of Sydney, Sydney, NSW, Australia
7 shared publications- Fariba Dehghani
School of Chemical and Biomolecular Engineering The University of Sydney Sydney NSW Australia
6 shared publications - Sina Naficy
School of Chemical and Biomolecular Engineering The University of Sydney Sydney NSW 2006 Australia
5 shared publications - Riccardo Zulli
Department of Industrial Engineering University of Padova Padova Italy
4 shared publications - Ronil J. Rath
Department of Biochemistry and Chemistry, School of Agriculture, Biomedicine and Environment, La Trobe University, Melbourne, Australia
3 shared publications
Latest Publications
- 14 October 2026
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 14 (39) , 12293-12304
How different immobilization techniques affect enzyme performance: a biosensor case study
The same platform is used to investigate the effects of different immobilisation techniques on enzyme stability and performance.
- 14 October 2026
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 14 (39) , 12293-12304
How different immobilization techniques affect enzyme performance: a biosensor case study
The same platform is used to investigate the effects of different immobilisation techniques on enzyme stability and performance.
- Open Access
- 8 October 2026
- Published by Wiley in Advanced Materials Interfaces
- Vol. 13 (21)
Metal Compound‐Based Non‐Enzymatic Electrochemical Cholesterol Sensors: Emerging Materials and Mechanistic Insights
Cholesterol plays a vital role in cellular function, yet abnormal cholesterol levels are strongly associated with cardiovascular disease, creating a need for accurate and rapid detection. Conventional enzymatic sensors, although sensitive, are limited by enzyme instability, high cost, and short operational lifetimes. This review highlights recent advances in metal compound‐based non‐enzymatic electrochemical cholesterol sensors, which offer improved stability, affordability, and potential suitability for point‐of‐care applications. We examine the electrocatalytic mechanisms and material innovations underpinning these sensors, with a focus on metal oxides, metal sulfides, and oxide‐sulfide composites. Mechanistic insights are provided into nanostructuring, heterointerface engineering, and multicomponent integration as strategies for improving sensitivity, selectivity, and durability. Comparative analysis reveals condition‐dependent trade‐offs material classes rather than universal superiority in analytical performance. Finally, we identify key challenges, including reproducibility, antifouling, and clinical validation, and outline future directions toward scalable, biocompatible platforms for personalized cholesterol monitoring.
- 8 October 2026
- Published by Wiley in Advanced Materials Interfaces
- Vol. 13 (21)
Open AccessMetal Compound‐Based Non‐Enzymatic Electrochemical Cholesterol Sensors: Emerging Materials and Mechanistic Insights
Cholesterol plays a vital role in cellular function, yet abnormal cholesterol levels are strongly associated with cardiovascular disease, creating a need for accurate and rapid detection. Conventional enzymatic sensors, although sensitive, are limited by enzyme instability, high cost, and short operational lifetimes. This review highlights recent advances in metal compound‐based non‐enzymatic electrochemical cholesterol sensors, which offer improved stability, affordability, and potential suitability for point‐of‐care applications. We examine the electrocatalytic mechanisms and material innovations underpinning these sensors, with a focus on metal oxides, metal sulfides, and oxide‐sulfide composites. Mechanistic insights are provided into nanostructuring, heterointerface engineering, and multicomponent integration as strategies for improving sensitivity, selectivity, and durability. Comparative analysis reveals condition‐dependent trade‐offs material classes rather than universal superiority in analytical performance. Finally, we identify key challenges, including reproducibility, antifouling, and clinical validation, and outline future directions toward scalable, biocompatible platforms for personalized cholesterol monitoring.
- Open Access
Electrochemical aptasensors for ultrasensitive multiplexed detection: Towards a new era of precision diagnostics and environmental monitoring
Electrochemical aptamer‐based sensors (aptasensors) are rapidly transforming precision diagnostics and environmental monitoring through their exceptional selectivity, programmability and compatibility with miniaturised platforms. However, their broader impact remains limited by insufficient signal intensity and persistent challenges in achieving robust multiplexed detection. This review critically examines emerging strategies aimed at overcoming these barriers and advancing aptasensors towards ultrasensitive, multi‐analyte performance. Particular emphasis is placed on the synergistic integration of nanomaterials and aptamer engineering, alongside state‐of‐the‐art signal amplification approaches that enhance both sensitivity and specificity. Diverse multiplexing strategies are evaluated, with applications spanning clinical diagnostics, food safety and environmental surveillance. The review also highlights the growing influence of artificial intelligence (AI)‐driven aptamer design and the development of three‐dimensional (3D) hierarchical materials, outlining the technological trajectory shaping next‐generation multiplexed electrochemical aptasensors.
Open AccessElectrochemical aptasensors for ultrasensitive multiplexed detection: Towards a new era of precision diagnostics and environmental monitoring
Electrochemical aptamer‐based sensors (aptasensors) are rapidly transforming precision diagnostics and environmental monitoring through their exceptional selectivity, programmability and compatibility with miniaturised platforms. However, their broader impact remains limited by insufficient signal intensity and persistent challenges in achieving robust multiplexed detection. This review critically examines emerging strategies aimed at overcoming these barriers and advancing aptasensors towards ultrasensitive, multi‐analyte performance. Particular emphasis is placed on the synergistic integration of nanomaterials and aptamer engineering, alongside state‐of‐the‐art signal amplification approaches that enhance both sensitivity and specificity. Diverse multiplexing strategies are evaluated, with applications spanning clinical diagnostics, food safety and environmental surveillance. The review also highlights the growing influence of artificial intelligence (AI)‐driven aptamer design and the development of three‐dimensional (3D) hierarchical materials, outlining the technological trajectory shaping next‐generation multiplexed electrochemical aptasensors.
- 17 June 2026
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 8 (13) , 10185-10196
Comparative Analysis of Promising Hydrophobic Polymers for Biomedical Applications: Mechanical Properties and Susceptibility to Lipid-Induced Plasticization
- 17 June 2026
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 8 (13) , 10185-10196
Comparative Analysis of Promising Hydrophobic Polymers for Biomedical Applications: Mechanical Properties and Susceptibility to Lipid-Induced Plasticization
- Open Access
- 8 April 2026
- Published by Wiley
Strategies for Enhancing Sensitivity in Lateral Flow Assays
Lateral Flow Assays (LFAs) have become the foundation of point-of-care (POC) diagnostics, valued for their user-friendly format, cost-effectiveness, and rapid turnaround time. However, despite their widespread success, most notably in pregnancy testing and infectious disease monitoring, conventional colorimetric LFAs often suffer from insufficient sensitivity, limiting their utility for the early-stage detection of low-abundance biomarkers. This review provides a critical analysis of recent strategies have been developed to improve the sensitivity of these assays. Enhancement strategies are systematically classified into six distinct domains: (i) flow modulation techniques that optimise reaction kinetics; (ii) sample preconcentration methods; (iii) advanced signal transduction reporters beyond traditional gold nanoparticles; (iv) chemical signal amplification including nanozyme and enzymatic catalysis; (v) structural strategies for maximising label accumulation; and (vi) the engineering of aptamers as programmable recognition elements. Special emphasis is placed on ”reagent-free” and ”equipment-free” innovations that boost performance without compromising the inherent simplicity of the device. Finally, the emerging transition from passive biological selection to active molecular engineering is discussed, outlining the future trajectory of ultra-sensitive next-generation LFAs.
- 8 April 2026
- Published by Wiley
Open AccessStrategies for Enhancing Sensitivity in Lateral Flow Assays
Lateral Flow Assays (LFAs) have become the foundation of point-of-care (POC) diagnostics, valued for their user-friendly format, cost-effectiveness, and rapid turnaround time. However, despite their widespread success, most notably in pregnancy testing and infectious disease monitoring, conventional colorimetric LFAs often suffer from insufficient sensitivity, limiting their utility for the early-stage detection of low-abundance biomarkers. This review provides a critical analysis of recent strategies have been developed to improve the sensitivity of these assays. Enhancement strategies are systematically classified into six distinct domains: (i) flow modulation techniques that optimise reaction kinetics; (ii) sample preconcentration methods; (iii) advanced signal transduction reporters beyond traditional gold nanoparticles; (iv) chemical signal amplification including nanozyme and enzymatic catalysis; (v) structural strategies for maximising label accumulation; and (vi) the engineering of aptamers as programmable recognition elements. Special emphasis is placed on ”reagent-free” and ”equipment-free” innovations that boost performance without compromising the inherent simplicity of the device. Finally, the emerging transition from passive biological selection to active molecular engineering is discussed, outlining the future trajectory of ultra-sensitive next-generation LFAs.
- Open Access
Advances in cholesterol and lipoproteins detection for healthcare: A review
Cholesterol is currently one of the main biomarkers for the assessment of cardiovascular disease risk, with low‐ and high‐density lipoprotein measured in the global cardiovascular risk assessment. Nevertheless, the detection of these molecules still relies on traditional methods, which can be resource‐intensive. Research has been focusing on developing more rapid techniques for cholesterol detection, often emphasizing technologies suitable for point‐of‐care use to facilitate screening and diagnosis in decentralized or underserved settings. This review begins with an overview of cholesterol metabolism and biology, followed by an in‐depth examination of the various sensor technologies reported in the literature for detecting cholesterol in its different forms, including free (non‐esterified), esterified, and lipoprotein‐bound, ranging from enzymatic to non‐enzymatic approaches, such as molecularly imprinted polymers (MIPs). The functioning mechanism, advantages, and limitations of each type of sensor are discussed, leading to the final recommendations. Enzymatic sensors could prove preferable in the detection of free or esterified cholesterol, given their selectivity, whereas MIPs seem to have the edge in the detection of lipoproteins, with different studies demonstrating their applicability in human serum.
Open AccessAdvances in cholesterol and lipoproteins detection for healthcare: A review
Cholesterol is currently one of the main biomarkers for the assessment of cardiovascular disease risk, with low‐ and high‐density lipoprotein measured in the global cardiovascular risk assessment. Nevertheless, the detection of these molecules still relies on traditional methods, which can be resource‐intensive. Research has been focusing on developing more rapid techniques for cholesterol detection, often emphasizing technologies suitable for point‐of‐care use to facilitate screening and diagnosis in decentralized or underserved settings. This review begins with an overview of cholesterol metabolism and biology, followed by an in‐depth examination of the various sensor technologies reported in the literature for detecting cholesterol in its different forms, including free (non‐esterified), esterified, and lipoprotein‐bound, ranging from enzymatic to non‐enzymatic approaches, such as molecularly imprinted polymers (MIPs). The functioning mechanism, advantages, and limitations of each type of sensor are discussed, leading to the final recommendations. Enzymatic sensors could prove preferable in the detection of free or esterified cholesterol, given their selectivity, whereas MIPs seem to have the edge in the detection of lipoproteins, with different studies demonstrating their applicability in human serum.
- Open Access
- 30 December 2025
- Published by Wiley in Advanced NanoBiomed Research
- Vol. 6 (4)
The Effect of Silk on the Stabilization of Labile Enzyme Lipoxygenase
Enzymes, as biological catalysts, are widely used for their excellent selectivity and sensitivity, playing a crucial role in biosensors, offering significant potential for monitoring food products and health conditions. However, enzyme activity can be compromised by environmental factors like high humidity, pH, and temperature variations. This study explores the feasibility of improving the stability of the unstable enzyme lipoxygenase (LOX) through immobilization using silk, a naturally occurring fibrous protein. A linoleic acid biosensor is designed by combining silk‐entrapped LOX with poly(3,4‐ethyloxy thiophene):poly(styrene sulfonate) (PEDOT:PSS) and horseradish peroxidase (HRP). The findings demonstrate that immobilizing LOX with different molecular weight silks extends the shelf‐life of the freeze‐dried PEDOT:PSS/HRP/LOX more than tenfold, from less than 1 day to 10 days. The results of the characterization tests (e.g., Fourier transform infrared spectroscopy, rheology) highlighted the interdependency between silk properties, such as its molecular weight, the silk conformation, and the pore shape and size, and enzyme stability. Low molecular weight silk resulted in the best performance, enabling storage at room temperature. It can therefore be concluded that immobilization with silk is an efficient method to enhance the shelf‐life of enzyme‐based biosensors, for diagnostic and other applications.
- 30 December 2025
- Published by Wiley in Advanced NanoBiomed Research
- Vol. 6 (4)
Open AccessThe Effect of Silk on the Stabilization of Labile Enzyme Lipoxygenase
Enzymes, as biological catalysts, are widely used for their excellent selectivity and sensitivity, playing a crucial role in biosensors, offering significant potential for monitoring food products and health conditions. However, enzyme activity can be compromised by environmental factors like high humidity, pH, and temperature variations. This study explores the feasibility of improving the stability of the unstable enzyme lipoxygenase (LOX) through immobilization using silk, a naturally occurring fibrous protein. A linoleic acid biosensor is designed by combining silk‐entrapped LOX with poly(3,4‐ethyloxy thiophene):poly(styrene sulfonate) (PEDOT:PSS) and horseradish peroxidase (HRP). The findings demonstrate that immobilizing LOX with different molecular weight silks extends the shelf‐life of the freeze‐dried PEDOT:PSS/HRP/LOX more than tenfold, from less than 1 day to 10 days. The results of the characterization tests (e.g., Fourier transform infrared spectroscopy, rheology) highlighted the interdependency between silk properties, such as its molecular weight, the silk conformation, and the pore shape and size, and enzyme stability. Low molecular weight silk resulted in the best performance, enabling storage at room temperature. It can therefore be concluded that immobilization with silk is an efficient method to enhance the shelf‐life of enzyme‐based biosensors, for diagnostic and other applications.
- Open Access
- 9 October 2025
- Published by Wiley
Advances in cholesterol and lipoproteins detection for healthcare: A review
Cholesterol is currently one of the main biomarkers for the assessment of cardiovascular diseases risk, with low-density and high-density lipoprotein measured in the global cardiovascular risk assessment. Nevertheless, the detection of these molecules still relies on traditional methods, which can be resource intensive. Research has been focusing on developing more rapid techniques for cholesterol detection, often emphasizing technologies suitable for point-of-care use to facilitate screening and diagnosis in decentralized or underserved settings. This review begins with an overview of cholesterol metabolism and biology, followed by an in-depth examination of the various sensor technologies reported in the literature for detecting cholesterol in its different forms, including free (non-esterified), esterified, and lipoprotein-bound, ranging from enzymatic to non-enzymatic approaches, such as molecularly imprinted polymers. The functioning mechanism, advantages, and limitations of each type of sensors are discussed, leading to the final recommendations. Enzymatic sensors could prove preferrable in the detection of free or esterified cholesterol, given their selectivity, while molecularly imprinted polymers seem to have the edge in the detection of lipoproteins, with different studies demonstrating their applicability in human serum.
- 9 October 2025
- Published by Wiley
Open AccessAdvances in cholesterol and lipoproteins detection for healthcare: A review
Cholesterol is currently one of the main biomarkers for the assessment of cardiovascular diseases risk, with low-density and high-density lipoprotein measured in the global cardiovascular risk assessment. Nevertheless, the detection of these molecules still relies on traditional methods, which can be resource intensive. Research has been focusing on developing more rapid techniques for cholesterol detection, often emphasizing technologies suitable for point-of-care use to facilitate screening and diagnosis in decentralized or underserved settings. This review begins with an overview of cholesterol metabolism and biology, followed by an in-depth examination of the various sensor technologies reported in the literature for detecting cholesterol in its different forms, including free (non-esterified), esterified, and lipoprotein-bound, ranging from enzymatic to non-enzymatic approaches, such as molecularly imprinted polymers. The functioning mechanism, advantages, and limitations of each type of sensors are discussed, leading to the final recommendations. Enzymatic sensors could prove preferrable in the detection of free or esterified cholesterol, given their selectivity, while molecularly imprinted polymers seem to have the edge in the detection of lipoproteins, with different studies demonstrating their applicability in human serum.
- Open Access
A paper‐based bi‐enzymatic sensor for chemiresistive glucose detection
At‐home testing of glucose levels is crucial for safe monitoring of a variety of diseases, such as pancreatitis, psoriasis, cirrhosis, acute myocardial infarction, and, of course, diabetes. Current blood tests are invasive, leading to the research of alternative biofluids such as saliva, tears, and sweat. Nevertheless, such fluids are limited in quantity and contain various interfering molecules, posing stringent technological requirements. In this study, a simple paper‐based glucose sensor is designed by using the conductive polymer poly(3,4‐ethylene‐dioxythiophene) polystyrene sulfonate (PEDOT:PSS) and a bi‐enzymatic solution of horseradish peroxidase (HRP) and glucose oxidase (GOx). Unlike most electrochemical glucose sensors, this sensor employs a chemiresistive mechanism, allowing simple configurations, low costs, and easy signal measurements. The designed sensor demonstrates a working range suitable for various biofluid analyses, such as saliva, with a linear detection range of 10 2 –10 4 µM while only requiring 40 µL sample volume. Detection in whole artificial saliva is carried out to demonstrate the sensors’ applicability. The limited analyte volume required, the suitable detection range, and the limit of detection achieved by this sensor make it an excellent candidate for developing a non‐invasive, at‐home glucose meter.
Open AccessA paper‐based bi‐enzymatic sensor for chemiresistive glucose detection
At‐home testing of glucose levels is crucial for safe monitoring of a variety of diseases, such as pancreatitis, psoriasis, cirrhosis, acute myocardial infarction, and, of course, diabetes. Current blood tests are invasive, leading to the research of alternative biofluids such as saliva, tears, and sweat. Nevertheless, such fluids are limited in quantity and contain various interfering molecules, posing stringent technological requirements. In this study, a simple paper‐based glucose sensor is designed by using the conductive polymer poly(3,4‐ethylene‐dioxythiophene) polystyrene sulfonate (PEDOT:PSS) and a bi‐enzymatic solution of horseradish peroxidase (HRP) and glucose oxidase (GOx). Unlike most electrochemical glucose sensors, this sensor employs a chemiresistive mechanism, allowing simple configurations, low costs, and easy signal measurements. The designed sensor demonstrates a working range suitable for various biofluid analyses, such as saliva, with a linear detection range of 10 2 –10 4 µM while only requiring 40 µL sample volume. Detection in whole artificial saliva is carried out to demonstrate the sensors’ applicability. The limited analyte volume required, the suitable detection range, and the limit of detection achieved by this sensor make it an excellent candidate for developing a non‐invasive, at‐home glucose meter.
- Open Access
- 20 April 2025
- Published by Elsevier in Sensors and Actuators Reports
- Vol. 9
Cascading chemiresistive paper-based enzymatic biosensor for urea detection
- 20 April 2025
- Published by Elsevier in Sensors and Actuators Reports
- Vol. 9
Open AccessCascading chemiresistive paper-based enzymatic biosensor for urea detection